The award winners for the ninth annual LMG Life Sciences Americas Awards are now offically live, following an in-person awards dinner at the Essex House in New York on Sept. 22. The winners include multiple individual, firm and in-house team categories, as well as special awards such as Impact Cases and Deals.
This year, the careers of five exceptional attorneys were recognized through their induction into the LMG Life Sciences Hall of Fame. We'd like to give a special congratulations to Dimitrios Drivas, Eldora Ellison, Eileen McMahon, Saul Morgenstern and Paul Radensky for the honors.
We are pleased to return to hosting our awards program as in-person event, taking place in its previous location in Midtown New York. Last year’s awards moved to an online web presentation due to safety concerns during the pandemic, and with return to the awards dinner format, we were excited to provide the chance for industry professionals to gather and connect.
The award categories cover the four main practice areas surveyed by the LMG Life Sciences research team, including regulatory, financial & corporate, intellectual property and litigation. The award results are determined through a rigorous research process involving in-depth firm submissions, practitioner interviews, client feedback and independent research. Visit our methodology page for more details.
Please contact George Reeves to discuss marketing opportunities and if you would like to receive a trophy.
Congratulations to all firm and individual winners this year.
Life Cycle
Life Cycle Firm of the Year – Canada
McCarthy Tétrault
Life Cycle Firm of the Year – United States
Arnold & Porter
2021 Hall of Fame Inductees
Dimitrios Drivas
White & Case
Eldora Ellison
Sterne Kessler Goldstein & Fox
Eileen McMahon
Torys
Saul Morgenstern
Arnold & Porter
Paul Radensky
McDermott Will & Emery
Financial & Corporate
Corporate Attorney of the Year
Peter Handrinos, Latham & Watkins
Licensing & Collaboration Attorney of the Year
Hannah Freeman, Ropes & Gray
M&A Attorney of the Year
Graham Robinson, Skadden Arps Slate Meagher & Flom
Venture Capital Attorney of the Year
Matthew Rossiter, Fenwick & West
Corporate Firm of the Year
Cooley
Licensing & Collaboration Firm of the Year
Ropes & Gray
M&A Firm of the Year
Latham & Watkins
Venture Capital Firm of the Year
Latham & Watkins
US Rising Star – Financial & Corporate
Adriana Tibbitts, Sidley Austin
Firm to Watch – Financial & Corporate
Orrick Herrington & Sutcliffe
Financial & Corporate In-House Team of the Year
Biogen
Regulatory
Regulatory Attorney of the Year: FDA Pharmaceutical
Daniel Kracov, Arnold & Porter
Regulatory Attorney of the Year: FDA Medical Device
Gregory Levine, Ropes & Gray
Regulatory Attorney of the Year: Pricing & Reimbursement
Meena Datta, Sidley Austin
US Rising Star – Regulatory
Jacqueline Berman, Morgan Lewis & Bockius
Regulatory Firm to Watch
Debevoise & Plimpton
Regulatory Firm of the Year
Arnold & Porter
Intellectual Property
Intellectual Property Boutique Firm of the Year
Fish & Richardson
Hatch-Waxman Litigator of the Year – Branded
Jane Love, Gibson Dunn & Crutcher
Hatch-Waxman Litigation Firm of the Year – Branded
Williams & Connolly
Hatch-Waxman Litigator of the Year – Generic
JC Rozendaal, Sterne Kessler Goldstein & Fox
Hatch-Waxman Litigation Firm of the Year – Generic
Perkins Coie
General Patent Litigator of the Year – California
Wayne Barsky, Gibson Dunn & Crutcher
General Patent Litigator of the Year – DC Metro
Amy Wigmore, WilmerHale
General Patent Litigator of the Year – Midwest
Michael Abernathy, Morgan Lewis & Bockius
General Patent Litigator of the Year – New England
Donald Ware, Foley Hoag
General Patent Litigator of the Year – New York
Jim Badke, Sidley Austin
General Patent Litigation Firm of the Year
Gibson Dunn & Crutcher
Patent Strategy Attorney of the Year – California
Lorna Tanner, Sheppard Mullin Richter & Hampton
Patent Strategy Attorney of the Year – DC Metro
Deborah Sterling, Sterne Kessler Goldstein & Fox
Patent Strategy Attorney of the Year – Massachusetts
Jane Remillard, Nelson Mullins Riley & Scarborough
Patent Strategy Attorney of the Year – Midwest
William Boudreaux, Barnes & Thornburg
Patent Strategy Attorney of the Year – New York
Carl Morales, Dechert
Patent Strategy Firm of the Year
Choate Hall & Stewart
Post-Grant Proceedings Attorney of the Year
Ching-Lee Fukuda, Sidley Austin
Appellate Litigator of the Year – Intellectual Property
Mark Perry, Gibson Dunn & Crutcher
US Rising Star – Intellectual Property
Vanessa Yen, King & Spalding
Inter-Partes Review Firm of the Year
Sidley Austin
Intellectual Property Firm to Watch
Barnes & Thornburg
Firm of the Year – Intellectual Property
Arnold & Porter
In-House Team of the Year – Intellectual Property
Regeneron
Litigation & Enforcement
Product Liability Attorney of the Year
Steve Brody, O'Melveny & Myers
Product Liability Firm of the Year
Tucker Ellis
Government Investigations Attorney of the Year
Brien O’Connor, Ropes & Gray
Government Investigations Firm of the Year
King & Spalding
Antitrust Practitioner of the Year
Ian Simmons, O’Melveny & Myers
Antitrust Firm of the Year
White & Case
Canada
Canadian Product Liability Attorney of the Year
Peter Pliszka, Fasken Martineau DuMoulin
Canadian Product Liability Firm of the Year
Norton Rose Fulbright
Canadian Patent Litigator of the Year
Kristin Wall, Norton Rose Fulbright
Canadian Patent Litigation Firm of the Year
McCarthy Tétrault
Canadian Patent Strategy Practitioner of the Year
Lisa Melanson, McCarthy Tétrault
Canadian Patent Strategy Firm of the Year
Smart & Biggar
Canadian Regulatory Attorney of the Year
Mathieu Gagné, Fasken Martineau DuMoulin
Canadian Financial & Corporate Attorney of the Year
Cheryl Reicin, Torys
Canadian Financial & Corporate Firm of the Year
McCarthy Tétrault
Canadian Rising Star
Jordan Scopa, Goodmans
Canadian In-House Team of the Year
Apotex
Impact Deals of the Year
Canada
AbCellera Biologics US$555 million IPO
Kardium Inc US$115 million financing round
Medicago and GlaxoSmithKline collaboration to develop Covid-19 vaccine candidate
United States
AstraZeneca’s $39 billion acquisition of Alexion
AstraZeneca and Daiichi Sankyo $6 billion joint development agreement
Centessa Pharmaceuticals $330 million IPO
Eli Lilly’s $2.65 billion collaboration agreement with Precision BioSciences
Gilead’s $21 billion acquisition of Immunomedics
Merck and Gilead Collaboration on HIV treatment
Neurocrine Biosciences and Takeda $2 billion collaboration
Sana Biotechnology $588 million IPO
Impact Cases of the Year
Canada (Patent)
Allergan v Sandoz (2020 FC 1189)
Eli Lilly v Mylan (2020 FC 816)
Natco Pharma v Minister of Health and Gilead Sciences (2020 FC 788)
United States (Hatch-Waxman)
AstraZeneca et al v. Mylan Pharmaceuticals et al (ND of W. Va.)
Novartis Pharmaceuticals v. Accord Healthcare (Dist. of Del.)
Valeant Pharmaceuticals v. Mylan Pharmaceuticals (Fed Cir 2020)
United States (Patent)
Amgen v. Sanofi (Fed Cir 2021)
Baxalta v. Genentech (Fed Cir 2020)
C R Bard v. AngioDynamics (Fed Cir 2020)
Hologic v. Minerva (US Supreme Ct 2021)
United States v. Arthrex (US Supreme Ct 2021)
Vectura Limited v. GlaxoSmithKline (Fed Cir 2020)
United States (Non-IP Litigation)
In re Suboxone Antitrust Litigation (3rd Circuit)
Ixchel Pharma, LLC v. Biogen, Inc. (CA Supreme Ct)
Mentor Worldwide product liability litigations (9th Circuit)